✦ LIBER ✦

Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis

✍ Scribed by Mori, Masayoshi; Murata, Yusuke; Matsuo, Asami; Takemoto, Tomoyo; Mine, Kazunori

Book ID: 121582639
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 583 KB
Volume: 3
Category: Article
ISSN: 2193-8253
DOI: 10.1007/s40120-013-0015-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of blepharospasm wi

Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: A case report

✍ Tetsuya Takahashi; Tetsuhito Murata; Yuji Wada 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Chronic treatment with tandospirone, a 5

Chronic treatment with tandospirone, a 5-HT1A receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats

✍ Uehara, Takashi; Matsuoka, Tadasu; Itoh, Hiroko; Sumiyoshi, Tomiki 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 433 KB

The partial 5-HT1A receptor agonist busp

The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica)

✍ Marta Grabiec; Kris Turlejski; Rouzanna L. Djavadian 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Treatment of cognitive dysfunction in ch

Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist

✍ Danijela Piškulić; James S. Olver; Paul Maruff; Trevor R. Norman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Objectives To assess effects of a semi‐acute administration of buspirone in comparison to a placebo on cognitive function and negative symptoms in patients with schizophrenia and schizoaffective disorder. ## Methods In a 6‐week, double‐blind, placebo‐controlled, independent groups

Hippocampal Bcl-2 expression is selectiv

Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT1A or 5-HT2C/2B receptor antagonists

✍ Fraser Murray; Peter H. Hutson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Chronic treatment with a benzodiazepine

Chronic treatment with a benzodiazepine agonist in vivo increases the actions of the benzodiazepine partial inverse agonist, FG7142, on the hippocampal slice in vitro

✍ H.J. Little; M. Andreasen; J.D.C. Lambert 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 703 KB